AIM ImmunoTech Stock

AIM ImmunoTech Liabilities 2024

AIM ImmunoTech Liabilities

9.15 M USD

Ticker

AIM

ISIN

US00901B1052

WKN

A2PREX

In 2024, AIM ImmunoTech's total liabilities amounted to 9.15 M USD, a 352.82% difference from the 2.02 M USD total liabilities in the previous year.

AIM ImmunoTech Aktienanalyse

What does AIM ImmunoTech do?

AIM ImmunoTech Inc is a US-based biotechnology company that focuses on the development of immunotherapeutics and diagnostics for humans and animals. The company has been in operation for over 30 years and specializes in the treatment of viral and autoimmune diseases. AIM ImmunoTech ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing AIM ImmunoTech's Liabilities

AIM ImmunoTech's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating AIM ImmunoTech's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing AIM ImmunoTech's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

AIM ImmunoTech's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in AIM ImmunoTech’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about AIM ImmunoTech stock

What is the level of liabilities of AIM ImmunoTech this year?

AIM ImmunoTech has a debt balance of 9.15 M USD this year.

What were the liabilities of AIM ImmunoTech compared to the previous year?

The liabilities of AIM ImmunoTech have increased by 352.82% increased compared to the previous year.

What are the consequences of high debt for investors of AIM ImmunoTech?

High liabilities can pose a risk for investors of AIM ImmunoTech, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in AIM ImmunoTech?

Low liabilities mean that AIM ImmunoTech has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of AIM ImmunoTech affect the company?

An increase in liabilities of AIM ImmunoTech can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of AIM ImmunoTech affect the company?

A decrease in the liabilities of AIM ImmunoTech can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of AIM ImmunoTech?

Some factors that can influence the liabilities of AIM ImmunoTech include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of AIM ImmunoTech so important for investors?

The liabilities of AIM ImmunoTech are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can AIM ImmunoTech take to modify the liabilities?

To change its liabilities, AIM ImmunoTech can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does AIM ImmunoTech pay?

Over the past 12 months, AIM ImmunoTech paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, AIM ImmunoTech is expected to pay a dividend of 0 USD.

What is the dividend yield of AIM ImmunoTech?

The current dividend yield of AIM ImmunoTech is .

When does AIM ImmunoTech pay dividends?

AIM ImmunoTech pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of AIM ImmunoTech?

AIM ImmunoTech paid dividends every year for the past 0 years.

What is the dividend of AIM ImmunoTech?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is AIM ImmunoTech located?

AIM ImmunoTech is assigned to the 'Health' sector.

Wann musste ich die Aktien von AIM ImmunoTech kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of AIM ImmunoTech from 12/3/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/3/2024.

When did AIM ImmunoTech pay the last dividend?

The last dividend was paid out on 12/3/2024.

What was the dividend of AIM ImmunoTech in the year 2023?

In the year 2023, AIM ImmunoTech distributed 0 USD as dividends.

In which currency does AIM ImmunoTech pay out the dividend?

The dividends of AIM ImmunoTech are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von AIM ImmunoTech

Our stock analysis for AIM ImmunoTech Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of AIM ImmunoTech Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.